Credit Suisse: Copaxone sales to plunge 90%
Credit Suisse: Copaxone sales to plunge 90%
Credit Suisse sees Copaxone sales falling from $4 billion annually to $400,000 in 2019 and predicts annual sales of over $1 billion for Laquinimod..... Read More - http://www.ms-uk.org/copaxone
MS-UK - http://www.ms-uk.org/